Follow The Filings

XGN Exagen Inc.

Health Care, filed as EXAGEN INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 1 Owner
  • $1.4M
  • 1 add

In 2026 Q2 First Eagle Investment Management added to Exagen.

Who owns XGN

Sorted by value, long equity only, as of 2026 Q2.

History
First Eagle Investment Management <0.01% Add +145.1% 306,965 $1.4M History

1 current, options excluded

Insider trades

Open-market buys and sales by XGN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All XGN insider trades
  • $104K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Jorey Chernett 10% owner
    Buy
    $104K 14,000 shares at $7.46 +0.5% to stake
    Traded Oct 19 Filed Oct 20
    ↗

Also filed in the last 12 months, not counted as buying or selling: 5 stock grants and 5 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $52.55M $55.64M $66.58M
Gross profit — $33.11M $38.8M
Gross margin * — 59.5% 58.3%
Net income -$23.69M -$15.12M -$19.95M
Net margin * -45.1% -27.2% -30.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $47.84M $36.46M $48.89M
Total non-current assets * $9.1M $8.23M $9.13M
Total assets $56.94M $44.69M $58.02M
Total current liabilities $11.9M $13.51M $14.16M
Total non-current liabilities * $22.35M $21.64M $26.41M
Total equity $22.69M $9.54M $17.45M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$14.46M -$13.28M -$13.62M
Cash from investing -$804,000 -$515,000 -$626,000
Cash from financing -$10.63M -$0.663M $24.44M
Net change in cash -$25.9M -$14.46M $10.18M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.